GARRY ARTHUR NEIL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARRY ARTHUR NEIL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARRY ARTHUR NEIL. GARRY ARTHUR NEIL is Director in ARENA PHARMACEUTICALS INC ($ARNA) and Chief Scientific Officer in MEDGENICS, INC. ($MDGN) and Global Head of R&D in MEDGENICS, INC. ($MDGN) and Director in GTX INC /DE/ ($GTXI) and Chief Medical Officer in Cerecor Inc. ($CERC) and Chief Scientific Officer in Cerecor Inc. ($CERC).
Latest Insider Trading Transactions of GARRY ARTHUR NEIL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNMX, ARNA, CERC, ONCT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
| Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 3,067 | 0 | 11,217 | 8.2 K to 11.2 K (+37.63 %) |
| Jun 14 2021 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 2.28 | 3,692 | 8,418 | 81,372 | 77.7 K to 81.4 K (+4.75 %) |
| Jan 28 2021 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 3.32 | 260,000 | 863,200 | 260,000 | |
| Dec 14 2020 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 2.28 | 3,599 | 8,199 | 77,680 | 74.1 K to 77.7 K (+4.86 %) |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 2,446 | 0 | 8,150 | 5.7 K to 8.2 K (+42.88 %) |
| Jun 11 2020 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 2.28 | 1,799 | 4,098 | 74,081 | 72.3 K to 74.1 K (+2.49 %) |
| Feb 05 2020 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Medical Offic ... | Option Exercise | A | 3.98 | 800,000 | 3,184,000 | 800,000 | |
| Feb 05 2020 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Medical Offic ... | Grant | A | 0.00 | 72,282 | 0 | 72,282 | 0 to 72.3 K |
| Feb 05 2020 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Medical Offic ... | Option Exercise | A | 3.98 | 800,000 | 3,184,000 | 800,000 | |
| Feb 05 2020 | CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Medical Offic ... | Grant | A | 0.00 | 72,282 | 0 | 72,282 | 0 to 72.3 K |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 1.55 | 261,000 | 404,550 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 1.51 | 300,000 | 453,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 2.84 | 13,334 | 37,869 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 1.32 | 100,000 | 132,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 4.91 | 200,000 | 982,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 4.83 | 200,000 | 966,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 7.01 | 200,000 | 1,402,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 6.45 | 13,532 | 87,281 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | D | 4.22 | 900,000 | 3,798,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Sell | D | 0.00 | 2,164,150 | 0 | 0 | 2.2 M to 0 (-100.00 %) |
| Dec 09 2019 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,164,150 | 114.8 K to 2.2 M (+1,785.58 %) |
| Dec 09 2019 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,164,150 | 114.8 K to 2.2 M (+1,785.58 %) |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 2,654 | 0 | 5,704 | 3.1 K to 5.7 K (+87.02 %) |
| Jan 03 2019 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 0.86 | 14,535 | 12,500 | 36,759 | 22.2 K to 36.8 K (+65.40 %) |
| Oct 02 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 1.50 | 8,333 | 12,500 | 22,224 | 13.9 K to 22.2 K (+59.99 %) |
| Jul 03 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 15.47 | 808 | 12,500 | 13,891 | 13.1 K to 13.9 K (+6.18 %) |
| Jun 18 2018 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 1.55 | 261,000 | 404,550 | 261,000 | |
| Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
| Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 3,050 | 0 | 3,050 | 0 to 3.1 K |
| May 16 2018 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 1.51 | 300,000 | 453,000 | 300,000 | |
| May 11 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Option Exercise | A | 17.20 | 7,500 | 129,000 | 7,500 | |
| Apr 03 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 17.47 | 716 | 12,509 | 13,083 | 12.4 K to 13.1 K (+5.79 %) |
| Apr 03 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 17.47 | 716 | 12,509 | 13,083 | 12.4 K to 13.1 K (+5.79 %) |
| Jan 04 2018 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 11.46 | 1,091 | 12,503 | 12,367 | 11.3 K to 12.4 K (+9.68 %) |
| Oct 18 2017 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | P | 2.84 | 13,344 | 37,897 | 13,344 | |
| Oct 18 2017 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 1.26 | 75,000 | 94,500 | 114,774 | 39.8 K to 114.8 K (+188.57 %) |
| Oct 04 2017 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 7.94 | 1,574 | 12,498 | 11,277 | 9.7 K to 11.3 K (+16.22 %) |
| Aug 15 2017 | GNMX | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 1.32 | 400,000 | 528,000 | 400,000 | |
| Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
| Apr 05 2017 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 4.90 | 2,551 | 12,500 | 7,326 | 4.8 K to 7.3 K (+53.42 %) |
| Feb 17 2017 | MDGN | Aevi Genomic Medic ... | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 4.91 | 200,000 | 982,000 | 200,000 | |
| Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 1.46 | 41,666 | 60,832 | 41,666 | |
| Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | NEIL GARRY ARTHUR | Director | Option Exercise | A | 1.46 | 75,000 | 109,500 | 75,000 | |
| Jan 04 2017 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 5.21 | 2,399 | 12,499 | 4,775 | 2.4 K to 4.8 K (+100.97 %) |
| Oct 04 2016 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 16,447 | 0 | 23,757 | 7.3 K to 23.8 K (+224.99 %) |
| Sep 06 2016 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Grant | A | 0.00 | 7,310 | 0 | 7,310 | 0 to 7.3 K |
| Sep 01 2016 | GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Option Exercise | A | 0.58 | 100,000 | 58,000 | 100,000 | |
| Apr 19 2016 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 4.83 | 200,000 | 966,000 | 200,000 | |
| Oct 08 2015 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 6.50 | 15,384 | 99,996 | 39,774 | 24.4 K to 39.8 K (+63.08 %) |
| Sep 17 2013 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Global Head of R&D | Option Exercise | A | 4.22 | 900,000 | 3,798,000 | 900,000 |
Page: 1